Calfactant
| Clinical data | |
|---|---|
| Trade names | Infasurf | 
| Pregnancy category | 
 | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| CAS Number | |
| ChemSpider | 
 | 
| UNII | |
| ChEMBL | |
|   (what is this?)  (verify) | |
Calfactant, also known as Infasurf,[1] is an intratracheal suspension derived from the natural surfactant in calf lungs. It is used in premature infants with lung surfactant deficiency that causes infant respiratory distress syndrome (IRDS).[2]
Mechanism of action
Lung surfactant is essential for effective ventilation as it modifies alveolar surface tension.[3] IRDS is caused by a lung surfactant deficiency. Calfactant serves as a substitute for the natural surfactant.[2]
References
- ^ "Infasurf". Archived from the original on 2011-12-09. Retrieved 2011-12-16.
- ^ a b Drugs.com: "Calfactant". Drugs.com.
- ^ Schurch S, Lee M, Gehr P (1992). "Pulmonary surfactant: Surface properties and function of alveolar and airway surfactant". Pure and Applied Chemistry. 64 (11): 1745–1750. doi:10.1351/pac199264111745. S2CID 97007574.